Malaysia · Delayed Price · Currency is MYR LAC Med Berhad Statistics
Total Valuation
LAC Med Berhad has a market cap or net worth of MYR 280.00 million. The enterprise value is 239.83 million.
| Market Cap | 280.00M |
| Enterprise Value | 239.83M |
Important Dates
The next estimated earnings date is Friday, June 12, 2026.
| Earnings Date | Jun 12, 2026 |
| Ex-Dividend Date | May 26, 2026 |
Share Statistics
LAC Med Berhad has 400.00 million shares outstanding. The number of shares has increased by 10,701.44% in one year.
| Current Share Class | 400.00M |
| Shares Outstanding | 400.00M |
| Shares Change (YoY) | +10,701.44% |
| Shares Change (QoQ) | +1.74% |
| Owned by Insiders (%) | 77.08% |
| Owned by Institutions (%) | 9.82% |
| Float | 88.19M |
Valuation Ratios
The trailing PE ratio is 8.41.
| PE Ratio | 8.41 |
| Forward PE | n/a |
| PS Ratio | 1.53 |
| PB Ratio | 2.34 |
| P/TBV Ratio | 2.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.91, with an EV/FCF ratio of -8.81.
| EV / Earnings | 13.34 |
| EV / Sales | 1.31 |
| EV / EBITDA | 8.91 |
| EV / EBIT | 9.60 |
| EV / FCF | -8.81 |
Financial Position
The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.26.
| Current Ratio | 2.19 |
| Quick Ratio | 1.87 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | -1.13 |
| Interest Coverage | 21.36 |
Financial Efficiency
Return on equity (ROE) is 20.75% and return on invested capital (ROIC) is 25.38%.
| Return on Equity (ROE) | 20.75% |
| Return on Assets (ROA) | 9.37% |
| Return on Invested Capital (ROIC) | 25.38% |
| Return on Capital Employed (ROCE) | 20.04% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.84M |
| Profits Per Employee | 179,792 |
| Employee Count | 100 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 5.19 |
Taxes
In the past 12 months, LAC Med Berhad has paid 7.64 million in taxes.
| Income Tax | 7.64M |
| Effective Tax Rate | 29.89% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 23.73 |
| Average Volume (20 Days) | 556,325 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LAC Med Berhad had revenue of MYR 183.55 million and earned 17.98 million in profits. Earnings per share was 0.08.
| Revenue | 183.55M |
| Gross Profit | 51.73M |
| Operating Income | 24.98M |
| Pretax Income | 25.55M |
| Net Income | 17.98M |
| EBITDA | 26.75M |
| EBIT | 24.98M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 70.83 million in cash and 30.62 million in debt, with a net cash position of 40.21 million or 0.10 per share.
| Cash & Cash Equivalents | 70.83M |
| Total Debt | 30.62M |
| Net Cash | 40.21M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 119.90M |
| Book Value Per Share | 0.30 |
| Working Capital | 107.48M |
Cash Flow
In the last 12 months, operating cash flow was -15.73 million and capital expenditures -11.48 million, giving a free cash flow of -27.22 million.
| Operating Cash Flow | -15.73M |
| Capital Expenditures | -11.48M |
| Depreciation & Amortization | 1.77M |
| Net Borrowing | 12.29M |
| Free Cash Flow | -27.22M |
| FCF Per Share | -0.07 |
Margins
Gross margin is 28.19%, with operating and profit margins of 13.61% and 9.80%.
| Gross Margin | 28.19% |
| Operating Margin | 13.61% |
| Pretax Margin | 13.92% |
| Profit Margin | 9.80% |
| EBITDA Margin | 14.57% |
| EBIT Margin | 13.61% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.93%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.93% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 27.81% |
| Buyback Yield | -10,701.44% |
| Shareholder Yield | -10,700.53% |
| Earnings Yield | 6.42% |
| FCF Yield | -9.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LAC Med Berhad has an Altman Z-Score of 4.68 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.68 |
| Piotroski F-Score | 5 |